Kilitch Drugs (India) Today
| KILITCH Stock | 312.55 5.35 1.68% |
PerformanceWeak
| Odds Of DistressVery Low
|
Kilitch Drugs is trading at 312.55 as of the 26th of February 2025. This is a 1.68 percent decrease since the beginning of the trading day. The stock's open price was 317.9. Kilitch Drugs has a very small chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 28th of November 2024 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Kilitch Drugs is entity of India. It is traded as Stock on NSE exchange. The company has 16.08 M outstanding shares. More on Kilitch Drugs Limited
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Kilitch Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Kilitch Drugs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Kilitch Drugs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Drugs, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Kilitch Drugs' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Kilitch Drugs' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsKilitch Drugs can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Kilitch Drugs' financial leverage. It provides some insight into what part of Kilitch Drugs' total assets is financed by creditors.
| |||||
Kilitch Drugs Limited (KILITCH) is traded on National Stock Exchange of India in India and employs 168 people. Kilitch Drugs is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kilitch Drugs's market, we take the total number of its shares issued and multiply it by Kilitch Drugs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kilitch Drugs Limited operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 16.08 M outstanding shares.
Kilitch Drugs Limited has accumulated about 1.34 M in cash with (56.69 M) of positive cash flow from operations.
Check Kilitch Drugs Probability Of Bankruptcy
Ownership AllocationKilitch Drugs Limited maintains a total of 16.08 Million outstanding shares. Kilitch Drugs Limited secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.15 % of Kilitch Drugs Limited outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kilitch Ownership Details
Kilitch Drugs Limited Risk Profiles
Although Kilitch Drugs' alpha and beta are two of the key measurements used to evaluate Kilitch Drugs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.58 | |||
| Semi Deviation | 1.87 | |||
| Standard Deviation | 2.11 | |||
| Variance | 4.47 |
Kilitch Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kilitch Drugs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Kilitch Drugs Corporate Management
Elected by the shareholders, the Kilitch Drugs' board of directors comprises two types of representatives: Kilitch Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kilitch. The board's role is to monitor Kilitch Drugs' management team and ensure that shareholders' interests are well served. Kilitch Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kilitch Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mukund Mehta | Executive MD | Profile | |
| LLB BCom | Executive MD | Profile | |
| Sunil Jain | Chief Officer | Profile | |
| Pushpa Nyoupane | Company Officer | Profile | |
| Rajesh Khatri | General Administration | Profile |
Other Information on Investing in Kilitch Stock
Kilitch Drugs financial ratios help investors to determine whether Kilitch Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kilitch with respect to the benefits of owning Kilitch Drugs security.